Camlin Fine Sciences promoter Ashish S. Dandekar has issued a corrected disclosure regarding the pledge of 18,00,000 equity shares, clarifying that the shares were pledged to Ashika Credit Capital Limited, not HDFC Bank Ltd. as initially reported. The correction was submitted on March 5, 2026, following the original disclosure made on February 27, 2026.

Corrected Share Pledge Details

The promoter acknowledged an inadvertent error in the original filing, where the beneficiary entity was incorrectly mentioned. The corrected details of the share pledge transaction are as follows:

Promoter Shareholding Position

Following the pledge creation, Dandekar's overall shareholding and encumbrance position remains as previously disclosed:

Regulatory Compliance and Correction

The revised disclosure was made in compliance with Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The correction was submitted to both BSE Limited and National Stock Exchange of India Limited, along with the company secretary. The promoter emphasized that while the beneficiary name was incorrect in the original filing, all other details including the pledge amount, date, and purpose remained accurate.

Corporate Purpose

The pledged shares continue to serve the purpose of facilitating the company's borrowing requirements through Ashika Credit Capital Limited. This represents a standard corporate financing arrangement where promoter shares are used as collateral to support the company's funding needs, increasing the promoter's total encumbered holdings from 70,00,000 shares to 88,00,000 shares.

Camlin Fine Sciences Limited has received a regulatory disclosure from promoter Ashish S. Dandekar regarding the release of pledge on equity shares under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The disclosure was submitted to both BSE Limited and National Stock Exchange of India Limited on February 19, 2026.

Pledge Release Details

The promoter executed the release of pledge on 30,00,000 equity shares on February 18, 2026. This transaction represents a significant reduction in the encumbered shareholding of the promoter in the company.

Promoter Shareholding Structure

Ashish S. Dandekar's shareholding pattern shows his substantial stake in the company along with the encumbrance details before and after the pledge release.

Regulatory Compliance

The disclosure has been made in compliance with Regulation 31(1) and 31(2) of SEBI SAST Regulations. The promoter has submitted the required documentation to:

• BSE Limited (Scrip Code: 532834)
• National Stock Exchange of India Limited (Symbol: CAMLINFINE)
• Company Secretary of Camlin Fine Sciences Limited

This pledge release reduces the overall encumbered shareholding of the promoter from 5.21% to 3.65% of the company's total share capital, indicating a partial deleveraging of the promoter's stake in the company.